ETHEREUM: THE RUN IS ABOUT TO BEGIN
3 extracted signals · 0 resolved · 3 still active
Jordan CamirandIndependent analyst profile- Source published
- 26 Jul 2026, 22:30 UTC
- Recorded by Tahlil Plus
- 16 Aug 2026, 13:27 UTC
AI-generated source summary
The analysis focuses on three key cryptocurrency assets: ETHUSD, ETHBTC, and BTCUSD, along with the USDT dominance chart. The primary technical observation is the potential for significant upward movement in ETHUSD and ETHBTC. ETHUSD is seen to be breaking out of a long-term downtrend and is predicted to reach $10,000, with a failure bound at $1400. The ETHBTC pair also shows signs of breaking a long-term downtrend, with a target of 0.06000 and a failure bound at 0.02000, suggesting ETH may outperform BTC. BTCUSD is currently in an accumulation range, trading sideways, with the potential for a move to $80,000 if it holds above $60,000, which would indicate a bullish continuation. The USDT dominance chart exhibits a bearish divergence on the two-week timeframe, with a higher high on price and a lower high on the RSI, suggesting a potential downtrend for USDT dominance, which implies that other cryptocurrencies, including ETH and BTC, may rally.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
3 eligible signals linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
3 signals remain active.
Jordan Camirand
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.